Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
THE OVERVIEW OF ORPHAN DRUG UTILIZATION IN TAIWAN IN 2017
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: HSIEH, Yow-Wen (China Medical University Hospital, Pharmacy, China Taiwan)
- Co-author(s): Yow-Wen Hsieh: Pharmacy, China Medical University Hospital, Taichung, China Taiwan
Yih-Dih Cheng: Pharmacy, China Medical University Hospital, Taichung, China Taiwan
Yu-Ping Yang: Pharmacy, China Medical University Hospital, Taichung, China Taiwan - Abstract:
Background
The analysis of the orphan drug utilization is very important for clinicians and rare disease patientsMethods
In order to let all rare disease patients obtain medication smoothly, the government has even created several regulations related to orphan drugs management such as the Ad Hoc Applications for Orphan Drugs Regulatiom to support.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019